GlobalData on MSN7mon
Boehringer Ingelheim acquires Nerio Therapeutics for $1.3bnBoehringer plans to develop Nerio's inhibitors as standalone treatments and in combination with other cancer therapies being ...
Boehringer Ingelheim Pharmaceuticals, Inc. Welcomes Brian Hilberdink as President, U.S. Human Pharma
RIDGEFIELD, Conn., Feb. 20, 2025 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. announced today the appointment of Brian Hilberdink as President, U.S ...
Boehringer Ingelheim has joined forces with ... who is chief executive and co-founder of Brainomix, a spinout from the University of Oxford in the UK. "This will enable earlier access to ...
Boehringer Ingelheim has prevailed in the trial of two lawsuits claiming that its discontinued heartburn drug Zantac caused cancer, both of which had previously ended with hung juries. November 22 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback